NCT01883999View on ClinicalTrials.gov

Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

June 30, 2021

Conditions
Common Iliac Artery AneurysmsAorto-iliac Aneurysms
Interventions
DEVICE

GORE® EXCLUDER® Iliac Branch Endoprosthesis

Trial Locations (1)

10065

Weill Cornell Medical Center, New York

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT01883999 - Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis | Biotech Hunter | Biotech Hunter